Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Vistagen Therap. Com

TRADE

NASDAQ: VTGNHealthcare / Drug Manufacturers - Other / California, U.S.A
1.38+0.02+1.47%Vol 99 0451Y Perf -24.02%
Jul 20th, 2018 16:00
BID1.27 ASK1.37
Open1.38 Previous Close1.36
Pre-Market- After-Trading-
 - -%  - -%
Target Price
11.33 
Analyst Rating
Strong Buy 1.00
Potencial %
721.01 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)32 
Earnings Rating
Neutral
Price Range Ratio 52wk %
35.20 
Earnings Date
13th Aug 2018

Today's Price Range

1.351.40

 

52wk Range

0.692.65

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
0.73%
3 Months
46.81%
6 Months
14.05%
1 Year
-24.02%
3 Years
-84.23%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTGN1.380.02001.47
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.10
Current Ratio 7.60
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.01
Interest Coverage -1 610.60
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-211.00
EBITDA Margin-210.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.57
PS Ratios 19.23
Price to Cash Flow -
Price to Free Cash Flow -4.60
Cash Flow Per Share -0.39
Price to Tangible Book4.57
Book Value per Share0.30
Enterprise Value (in ths.)21 253
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)247.74
ROE last 12 Months -414.00
Return on Assets (5Y Avg) -254.75
ROA last 12 Months -207.80
Return on Capital (5Y Avg) -
ROC last 12 Months -129.40
Return on invested Capital Q -50.22
Return on invested Capital Y-406.48
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.28-0.1932.14
Q03 2018--0.24-
Q02 2018--0.53-
Q01 2018--0.28-
Q04 2017--0.32-
Q03 2017--0.34-
Q02 2017--0.42-
----
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.2885.19Positive
3/2018 FY-1.49--
3/2019 FY-1.09--
----
Next Report Date13th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume99 045
Shares Outstanding (in ths.)23 040
Trades Count145
Dollar Volume126 307
Avg. Volume836 739
Avg. Weekly Volume267 384
Avg. Monthly Volume255 456
Avg. Quarterly Volume881 011

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

Bearish Bullish

45%55%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x